Royce & Associates LP purchased a new position in CryoPort Inc (NASDAQ:CYRX) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 137,200 shares of the consumer goods maker’s stock, valued at approximately $1,351,000. Royce & Associates LP owned 0.54% of CryoPort at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of CYRX. Northern Trust Corp increased its stake in CryoPort by 105.0% in the 2nd quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock worth $109,000 after buying an additional 11,358 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in CryoPort in the 3rd quarter worth about $118,000. Granite Investment Partners LLC purchased a new position in CryoPort in the 3rd quarter worth about $535,000. EAM Investors LLC purchased a new position in CryoPort in the 2nd quarter worth about $552,000. Finally, D.A. Davidson & CO. increased its stake in CryoPort by 16.6% in the 2nd quarter. D.A. Davidson & CO. now owns 137,000 shares of the consumer goods maker’s stock worth $674,000 after buying an additional 19,500 shares during the period. Institutional investors and hedge funds own 18.10% of the company’s stock.
Several research analysts recently commented on CYRX shares. Janney Montgomery Scott raised their price target on shares of CryoPort from $10.00 to $12.00 and gave the stock a “buy” rating in a research note on Tuesday, October 3rd. Roth Capital began coverage on shares of CryoPort in a research report on Thursday, November 30th. They set a “buy” rating and a $12.50 target price on the stock. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $33.50.
CryoPort Inc (NASDAQ CYRX) traded up $0.40 during trading hours on Friday, hitting $8.72. 33,439 shares of the stock were exchanged, compared to its average volume of 91,619. CryoPort Inc has a twelve month low of $1.96 and a twelve month high of $10.40. The company has a market cap of $222.72, a PE ratio of -17.10 and a beta of 0.21.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/14/royce-associates-lp-purchases-shares-of-137200-cryoport-inc-cyrx.html.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.